about
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled TrialsIntravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema.Ischemia-reperfusion injury in strokeCardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.Iodide protects heart tissue from reperfusion injury.Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.CMR of microvascular obstruction and hemorrhage in myocardial infarction.Imaging the myocardial microcirculation post-myocardial infarction.Choice of cell-delivery route for successful cell transplantation therapy for the heart.Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.Acute microvascular changes after subarachnoid hemorrhage and transient global cerebral ischemia.Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction.Effect of an Ilex paraguariensis (yerba mate) extract on infarct size in isolated rat hearts: the mechanisms involved.The Relation Between No-Reflow Phenomenon and Complete Blood Count Parameters.The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary interventionOptimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.New and revisited approaches to preserving the reperfused myocardium.The importance of no-reflow/microvascular obstruction in the STEMI patient.MRI demonstrates a decrease in myocardial infarct healing and increase in compensatory ventricular hypertrophy following mechanical microvascular obstruction.Capillary pericytes mediate coronary no-reflow after myocardial ischaemia.Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia-Reperfusion Injury: Impact of Ischemia and Reperfusion Length on Infarct Size and LDH Release.Cerebral Ischemic Reperfusion Injury Following Recanalization of Large Vessel Occlusions.Guidelines for Experimental Models of Myocardial Ischemia and Infarction.Detection of MAPK signal transduction proteins in an ischemia/reperfusion model of mouse intestine using in vivo cryotechnique.The actions of relaxin on the human cardiovascular system.The Oxygen Paradox, the French Paradox, and age-related diseases.Responses of Endothelial Cells Towards Ischemic Conditioning Following Acute Myocardial Infarction
P2860
Q26778578-60414CEC-9195-4A1D-AB42-70445A8FCC97Q30409710-D2876226-0593-46C8-9179-E8F351020152Q30884854-5CE3FD04-8539-4478-AA82-3929CEAE6592Q33653045-C20E17A9-D291-4DA3-A5E0-7A8CD13D5235Q33883312-F4A34256-C1BD-40D7-829C-C6BB39DA5FB8Q34473263-96D03753-608E-4AEF-859B-C1C0A42BB90BQ36366202-EDE88041-77B1-4A15-92F9-8D026179ED83Q36444582-38488D80-9F9F-42AE-9C2E-E8E4CAEA0BA1Q38038533-539BE27B-3579-409C-BDC4-7C9955D0E9C0Q38086843-27348108-C316-4B6A-8AD4-66EE40E31B60Q38543451-0AB231FC-58F1-44B2-A804-1FA16132E6FBQ38699009-73610331-1A10-4428-988B-39BFA0187D81Q39716168-922B66DA-1DE6-40DC-95D4-0975F4955735Q39879102-DADAB83D-C4BB-4F5C-8B20-770D71A9B2CEQ40217656-1DBA16D2-3BDE-452E-9EAA-45C04809B97BQ40612721-065FEF8D-462F-4C46-929E-C8092064F8B9Q41375104-2640FF99-AEB3-4274-955E-4277291CE9CFQ43102079-C546DC30-3B3C-45EF-82B0-D82D5CD9A709Q45064238-1AAF2C95-8FF3-4BBD-A853-F65C7C19E12BQ45304845-43ECB8B5-EDA6-48D5-B51C-6247F384C627Q46411115-6BF8A09A-FA2C-4FC6-A5F2-B2EC97C40099Q47094840-C7875047-DBC5-4AB5-8FDA-231BC26C4660Q47363519-46591D83-0A93-49F7-9A8A-1F6C455EAD6BQ48035381-B611E01B-65E4-4513-9506-CA482B7A3223Q49917885-CAF838F2-7EA3-4236-B0E4-84680C6C9353Q50884238-4D922D0B-EF9C-40B6-80C5-A1A6BD5DDC84Q52851745-720EFFFB-DCCF-4E63-B6AE-B89D4A06748FQ55384244-1EEA27FE-009A-4102-9F6F-40224B5162EDQ58566927-12C6E74E-675E-4D80-846E-35F3FDED1759
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
No-reflow phenomenon: maintaining vascular integrity.
@en
No-reflow phenomenon: maintaining vascular integrity.
@nl
type
label
No-reflow phenomenon: maintaining vascular integrity.
@en
No-reflow phenomenon: maintaining vascular integrity.
@nl
prefLabel
No-reflow phenomenon: maintaining vascular integrity.
@en
No-reflow phenomenon: maintaining vascular integrity.
@nl
P2860
P356
P1476
No-reflow phenomenon: maintaining vascular integrity.
@en
P2093
Robert A Kloner
P2860
P304
P356
10.1177/1074248411405990
P577
2011-09-01T00:00:00Z